Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Cited by (874)

Items 201–300 of 874

1. Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab
   Yuka Maeda, Hisashi Wada, Daisuke Sugiyama, Takuro Saito, Takuma Irie, Kota Itahashi, Kodai Minoura, Susumu Suzuki, Takashi Kojima, Kazuhiro Kakimi et al. · 2021 · Nature Communications
2. Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy
   Myriam Ben Khelil, Yann Godet, Syrine Abdeljaoued, Christophe Borg, Olivier Adotévi, Romain Loyon · 2022 · Cancers
3. Human NKp44+ Group 3 Innate Lymphoid Cells Associate with Tumor-Associated Tertiary Lymphoid Structures in Colorectal Cancer
   Atsuyo Ikeda, Takayuki Ogino, Hisako Kayama, Daisuke Okuzaki, Junichi Nishimura, Shiki Fujino, Norikatsu Miyoshi, Hidekazu Takahashi, Mamoru Uemura, Chu Matsuda et al. · 2020 · Cancer Immunology Research
4. Turning the Tide Against Regulatory T Cells
   SeongJun Han, Aras Toker, Zhe Qi Liu, Pamela S. Ohashi · 2019 · Frontiers in Oncology
5. Targeting regulatory T cells for immunotherapy in melanoma
   Lili Huang, Yeye Guo, Shujing Liu, Huaishan Wang, Jinjin Zhu, Lingling Ou, Xiaowei Xu · 2021 · Molecular Biomedicine
6. Gut microbiota in regulatory T cell generation and function: mechanisms and health implications
   Amit Sharma, Garima Sharma, Sin‐Hyeog Im · 2025 · Gut Microbes
7. GITR ligation enhances functionality of tumor‐infiltrating T cells in hepatocellular carcinoma
   Adriaan A. van Beek, Guoying Zhou, Michail Doukas, Patrick P.C. Boor, Lisanne Noordam, Shanta Mancham, Lucia Campos Carrascosa, Marieke van der Heide‐Mulder, Wojciech Grzegorz Polak, Jan N.M. IJzermans et al. · 2019 · International Journal of Cancer
8. FOXP3+ regulatory T cells and the immune escape in solid tumours
   Yiran Qiu, Shouyu Ke, Jieqiong Chen, Zhizhen Qin, Wenle Zhang, Yaqin Yuan, Dehua Meng, Gang Zhao, Kejin Wu, Bin Li et al. · 2022 · Frontiers in Immunology
9. Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment
   Antonia Reale, Tiffany T. Khong, Andrew G Spencer · 2022 · Journal of Clinical Medicine
10. Fusobacterium nucleatum induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers
    Han Sang Kim, Chang Gon Kim, Won Kyu Kim, Kyung‐A Kim, Jinseon Yoo, Byung Soh Min, Soonmyung Paik, Sang Joon Shin, Hyukmin Lee, Kyungwon Lee et al. · 2023 · Frontiers in Cellular and Infection Microbiology
11. Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
    Yijia Tang, Guangzu Cui, Haicong Liu, Ying Han, Changjing Cai, Ziyang Feng, Hong Shen, Shan Zeng · 2024 · 癌症：英文版
12. Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
    Takuma Matoba, Masaki Imai, Naganari Ohkura, Daisuke Kawakita, Kei Ijichi, Tatsuya Toyama, Akimichi Morita, Shingo Murakami, Shimon Sakaguchi, Sayuri Yamazaki · 2018 · International Journal of Cancer
13. Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients
    Yusuke Omura, Yuji Toiyama, Yoshinaga Okugawa, Chengzeng Yin, Tsunehiko Shigemori, Kurando Kusunoki, Yukina Kusunoki, Shozo Ide, Tadanobu Shimura, Hiroyuki Fujikawa et al. · 2020 · Cancer Immunology Immunotherapy
14. Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies
    Liu, Xu, Xu, Danhua, Huang, Chen, Guo, Yixian, Wang, Shuchang, Zhu, Chunchao, Xu, Jia, Zhang, Zizhen, Shen, Yanying, Zhao, Wenyi et al. · 2019 · Journal of Translational Medicine
15. Fusobacterium nucleatum and Colorectal Cancer
    Rongrong Li, Jilu Shen, Yuanhong Xu · 2022 · Infection and Drug Resistance
16. Iron metabolism in colorectal cancer: a balancing act
    Diogo Estêvão, Miguel da Cruz-Ribeiro, Ana Patrícia Cardoso, Ângela M. Costa, María José Oliveira, Tiago L. Duarte, Tânia Cruz · 2023 · Cellular Oncology
17. Immunological differences between colorectal cancer and normal mucosa uncover a prognostically relevant immune cell profile
    Katharina Strasser, Hanna Birnleitner, Andrea Beer, Dietmar Pils, Marlene C. Gerner, Klaus G. Schmetterer, Thomas Bachleitner‐Hofmann, Anton Stift, Michael M. Bergmann, Rudolf Oehler · 2018 · OncoImmunology
18. Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinoma
    Weiju Zhang, Sumei Yao, Hua Huang, Hao Zhou, Haomiao Zhou, Qishuang Wei, Tingting Bian, Hui Sun, Xiaoli Li, Jianguo Zhang et al. · 2021 · OncoImmunology
19. Unraveling resistance to immunotherapy in MSI-high colorectal cancer
    Heregger, Ronald, Huemer, Florian, Steiner, Markus, Gonzalez-Martinez, Alejandra, Greil, Richard, Weiss, Lukas · 2023 · Cancers
20. Regulatory T cell heterogeneity and therapy in autoimmune diseases
    Rui Zhang, Jinlin Miao, Ping Zhu · 2020 · Autoimmunity Reviews
21. Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer
    Koji Inamori, Yosuke Togashi, Shota Fukuoka, Kiwamu Akagi, Kouetsu Ogasawara, Takuma Irie, Daisuke Motooka, Yoichi Kobayashi, Daisuke Sugiyama, Motohiro Kojima et al. · 2021 · JCI Insight
22. Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
    Tomofumi Watanabe, Takamasa Ishino, Youki Ueda, Joji Nagasaki, Takuya Sadahira, Hiromichi Dansako, Motoo Araki, Yosuke Togashi · 2023 · Cancer Science
23. Immune biomarkers for chronic inflammation related complications in non-cancerous and cancerous diseases
    Yaron Meirow, Michal Baniyash · 2017 · Cancer Immunology Immunotherapy
24. Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients
    Ryo Kato, Makoto Yamasaki, Shinya Urakawa, Kentaro Nishida, Tomoki Makino, Akiko Morimoto-Okazawa, Atsunari Kawashima, Kota Iwahori, Susumu Suzuki, Ryuzo Ueda et al. · 2018 · Cancer Immunology Immunotherapy
25. Metagenomic analyses of the gut microbiota associated with colorectal adenoma
    Keisuke Saito, Shigeo Koido, Toshitaka Odamaki, Mikio Kajihara, Kumiko Kato, Sankichi Horiuchi, Sei Adachi, Hiroshi Arakawa, Sayumi Yoshida, Takafumi Akasu et al. · 2019 · PLoS ONE
26. Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy
    Akiko Ohno, Takashi Iwata, Yuki Katoh, Shiho Taniguchi, Kohsei Tanaka, Hiroshi Nishio, Masaru Nakamura, Tohru Morisada, Guanliang Chen, Miyuki Saito et al. · 2020 · Gynecologic Oncology
27. Bystander CD4 + T cells infiltrate human tumors and are phenotypically distinct
    Shamin Li, Summer Zhuang, Antja Heit, Si‐Lin Koo, Aaron C. Tan, I‐Ting Chow, William W. Kwok, Iain Beehuat Tan, Daniel S.W. Tan, Yannick Simoni et al. · 2022 · OncoImmunology
28. Tissue-specific control of latent CMV reactivation by regulatory T cells
    Maha Almanan, Jana L. Raynor, Allyson Sholl, Mei Wang, Claire Anne Chougnet, Rhonda D. Cardin, David A. Hildeman · 2017 · PLoS Pathogens
29. Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Hiroaki Saito, Yusuke Kono, Yuki Murakami, Yuji Shishido, Hirohiko Kuroda, Tomoyuki Matsunaga, Yoji Fukumoto, Tomohiro Osaki, Keigo Ashida, Yoshiyuki Fujiwara · 2018 · Anticancer Research
30. Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis
    Chuan Zhang, Dan Dang, Lele Cong, Hongyan Sun, Xianling Cong · 2021 · Cancer Medicine
31. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
    Varun Sasidharan Nair, Reem Saleh, Salman M. Toor, Farhan Sachal Cyprian, Eyad Elkord · 2021 · Cancer Immunology Immunotherapy
32. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
    Feng‐Ming Tien, Hsuan‐Hsuan Lu, Shu‐Yung Lin, Hsing-Chen Tsai · 2023 · Journal of Biomedical Science
33. Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations
    Junwei Ge, Xuan Yin, Lujun Chen · 2024 · Frontiers in Immunology
34. Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer
    Xiaowei Chen, Yoshihiro Takemoto, Huan Deng, Moritz A. Middelhoff, Richard A. Friedman, Timothy H. Chu, Michael Churchill, Yan Ma, Karan K. Nagar, Yagnesh H. Tailor et al. · 2017 · OncoImmunology
35. Predicting response to immunotherapy in gastric cancer via assessing perineural invasion-mediated inflammation in tumor microenvironment
    Xunjun Li, Yiyun Wang, ZhongYa Zhai, Qingyi Mao, Dianjie Chen, Luxi Xiao, Shuai Xu, Qilin Wu, Keming Chen, Qiantong Hou et al. · 2023 · Journal of Experimental & Clinical Cancer Research
36. The role of CD4+ T cells in tumor and chronic viral immune responses
    Luoyingzi Xie, Jingyi Fang, Juncheng Yu, Weinan Zhang, Zhiqiang He, Lilin Ye, Huaizhi Wang · 2023 · MedComm
37. Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified
    Shoko Nakayama, Taiji Yokote, Toshikazu Akioka, Nobuya Hiraoka, Uta Nishiwaki, Takuji Miyoshi, Kazuki Iwaki, Ayami Takayama, Yuki Masuda, Jun Hatooka et al. · 2017 · Blood Advances
38. Myeloid-derived suppressor cells and T regulatory cells in tumors: unraveling the dark side of the force
    Aikaterini Hatzioannou, Themis Alissafi, Panayotis Verginis · 2017 · Journal of Leukocyte Biology
39. Increased CD3+ T cells with a low FOXP3+/CD8+ T cell ratio can predict anti-PD-1 therapeutic response in non-small cell lung cancer patients
    Hyojin Kim, Hyun Jung Kwon, Yeon Bi Han, Soo Young Park, Eun Sun Kim, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung · 2018 · Modern Pathology
40. Foxo transcription factors in T cell biology and tumor immunity
    Luo, Chong T., Li, Ming O. · 2018 · Seminars in Cancer Biology
41. Tumor resident regulatory T cells
    Ariella Glasner, George Plitas · 2021 · Seminars in Immunology
42. The Clinicopathological and Prognostic Implications of FoxP3+ Regulatory T Cells in Patients with Colorectal Cancer: A Meta-Analysis
    Peipei Xu, Wei Fan, Zheng Zhang, June Wang, Ping Wang, Yirong Li, Mingxia Yu · 2017 · Frontiers in Physiology
43. Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer
    Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, Masaaki Iwatsuki, Yukiharu Hiyoshi, Yuji Miyamoto, Naoya Yoshida, Rong Wu, Hideo Baba · 2018 · Journal of Gastroenterology
44. Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity
    Lien Lybaert, Karim Y. Vermaelen, Bruno G. De Geest, Lutz Nuhn · 2018 · Journal of Controlled Release
45. Bacterial biofilm in colorectal cancer: What is the real mechanism of action?
    Rasoul Mirzaei, Hamed Mirzaei, Mohammad Yousef Alikhani, Mohammad Sholeh, Mohammad Reza Arabestani, Massoud Saidijam, Sajad Karampoor, Yaghoub Ahmadyousefi, Mohammad Shokri Moghadam, Gholam Reza Irajian et al. · 2020 · Microbial Pathogenesis
46. Mechanism and potential predictive biomarkers of immune checkpoint inhibitors in NSCLC
    Jialin Qu, Man Jiang, Li Wang, Deze Zhao, Kang Qin, Yun Wang, Junyan Tao, Xiaochun Zhang · 2020 · Biomedicine & Pharmacotherapy
47. Gut Microbiota Signatures in Tumor, Para-Cancerous, Normal Mucosa, and Feces in Colorectal Cancer Patients
    Yanmin Li, Hong Cao, Bojian Fei, Qizhong Gao, Wanya Yi, Weifeng Han, Chuanqing Bao, Jianmin Xu, Wei K. Zhao, Feng Zhang · 2022 · Frontiers in Cell and Developmental Biology
48. Checkpoints and beyond – Immunotherapy in colorectal cancer
    Tobias Gutting, Elke Burgermeister, Nicolai Härtel, Matthias P A Ebert · 2018 · Seminars in Cancer Biology
49. Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy
    Marieke E. Ijsselsteijn, Rebeca Sanz Pamplona, Fabienne Hermitte, Noel F.C.C. de Miranda · 2019 · Molecular Aspects of Medicine
50. Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management
    Khaled S. Allemailem, Mohammed A. Alsahli, Ahmad Almatroudi, Faris Alrumaihi, Waleed Al Abdulmonem, Amira A. Moawad, Wanian M Alwanian, Nahlah Makki Almansour, Arshad Husain Rahmani, Amjad Ali Khan · 2023 · International Journal of Nanomedicine
51. Systemic and local immunosuppression in glioblastoma and its prognostic significance
    Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, Marat P. Valikhov, Anastasia Alekseevna Chernysheva, Olga V. Abramova, Pavlov Ka, Vladimir Pavlovich Chekhonin · 2024 · Frontiers in Immunology
52. Regulatory T cells subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis and treatment strategy in melanoma
    Wenyi Huang, Byeong Seop Kim, Yichi Zhang, Li Lin, Gang Chai, Zhijie Zhao · 2024 · Environmental Toxicology
53. Regulatory T-cell Genes Drive Altered Immune Microenvironment in Adult Solid Cancers and Allow for Immune Contextual Patient Subtyping
    Jurriaan Brouwer‐Visser, Wei‐Yi Cheng, Anna Bauer‐Mehren, Daniela Maisel, Katharina Lechner, Emilia K. Andersson, Joel T. Dudley, Francesca Milletti · 2017 · Cancer Epidemiology Biomarkers & Prevention
54. A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity
    Wentao Pan, Qiuyun Luo, Xianglei Yan, Luping Yuan, Hanjie Yi, Lin Zhang, Baoxia Li, Yuxin Zhang, Jian Sun, Miao‐Zhen Qiu et al. · 2018 · Biochemical Pharmacology
55. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells
    Suniti Bhaumik, Michel‐Edwar Mickael, Monica Moran, Marion L. Spell, Rajatava Basu · 2021 · The Journal of Immunology
56. The role of immunotherapy in microsatellites stable metastatic colorectal cancer: State of the art and future perspectives
    Gandini, Annalice, Puglisi, Silvia, Pirrone, Chiara, Martelli, Valentino, Catalano, Fabio, Nardin, Simone, Seeber, Andreas, Puccini, Alberto, Sciallero, Stefania · 2023 · Frontiers in Oncology
57. Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells
    Gap Ryol Lee · 2017 · Mediators of Inflammation
58. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers
    Tomohiro Kikuchi, Kosaku Mimura, Mai Ashizawa, Hirokazu Okayama, Eisei Endo, Katsuharu Saito, Wataru Sakamoto, Shotaro Fujita, Hisahito Endo, Motonobu Saito et al. · 2019 · Cancer Immunology Immunotherapy
59. Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers
    Susumu Suzuki, Tetsuya Ogawa, Rui Sano, Taishi Takahara, Daisuke Inukai, Akira Satou, Hiromi Tsuchida, Kazuhiro Yoshikawa, Ryuzo Ueda, Toyonori Tsuzuki · 2020 · Cancer Science
60. Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells
    Shinya Urakawa, Makoto Yamasaki, Kumiko Goto, Miya Haruna, Michinari Hirata, Akiko Morimoto-Okazawa, Atsunari Kawashima, Kota Iwahori, Tomoki Makino, Yukinori Kurokawa et al. · 2019 · Cancer Immunology Immunotherapy
61. OMIP 071: A 31‐Parameter Flow Cytometry Panel for In‐Depth Immunophenotyping of Human T‐Cell Subsets Using Surface Markers
    Song‐Rong Wang, Na Zhong, Xin‐Mei Zhang, Zhibin Zhao, ROBERT S. BALDERAS, Liang Li, Zhe‐Xiong Lian · 2020 · Cytometry Part A
62. Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity
    Allan Relecom, Maysaloun Merhi, Varghese Philipose Inchakalody, Shahab Uddin M.S., Darawan Rinchai, Davide Bedognetti, Said Dermime · 2021 · Journal of Experimental & Clinical Cancer Research
63. Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf
    Fantini, Massimo Claudio, Favale, Agnese, Onali, Sara, Facciotti, Federica · 2020 · International Journal of Molecular Sciences
64. The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
    Noriko Goda, Shinsuke Sasada, Hideo Shigematsu, Norio Masumoto, Koji Arihiro, Hiroyoshi Nishikawa, Shimon Sakaguchi, Morihito Okada, Takayuki Kadoya · 2022 · Discover Oncology
65. Metabolic advantages of regulatory T cells dictated by cancer cells
    Masaki Kondo, Shogo Kumagai, Hiroyoshi Nishikawa · 2023 · International Immunology
66. Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis
    Yuze Wu, Yuheng Yan, Yarong Guo, Mengke Niu, Binghan Zhou, Jing Zhang, Pengfei Zhou, Qian Chu, Qi Mei, Ming Yi et al. · 2025 · Journal of Hematology & Oncology
67. The Different Functional Distribution of “Not Effector” T Cells (Treg/Tnull) in Colorectal Cancer
    Elena Niccolai, Federica Ricci, Edda Russo, Giulia Nannini, Giacomo Emmi, Antonio Taddei, Maria Novella Ringressi, Filippo Melli, Manouela Miloeva, Fabio Cianchi et al. · 2017 · Frontiers in Immunology
68. Interaction Between CCR6 + Th17 Cells and CD34 + Fibrocytes Promotes Inflammation: Implications in Graves' Orbitopathy in Chinese Population
    Sijie Fang, Yazhuo Huang, Xingtong Liu, Sisi Zhong, Ningjian Wang, Binbin Zhao, Yinwei Li, Jing Ping Sun, Yang Wang, Shuo Zhang et al. · 2018 · Investigative Ophthalmology & Visual Science
69. GPR15 Facilitates Recruitment of Regulatory T Cells to Promote Colorectal Cancer
    Alexandra Adamczyk, Eva Pastille, Jan Kehrmann, Vivian Pham Vu, Robert Geffers, Marie-Hélène Wasmer, Stefan Kasper, Martin Schüler, Christian M. Lange, Beat Muggli et al. · 2021 · Cancer Research
70. Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients
    Xianwei Mo, Xiaoliang Huang, Yan Feng, Chunyin Wei, Haizhou Liu, Haiming Ru, Haiquan Qin, Hao Lai, Guo Wu, Weishun Xie et al. · 2020 · OncoImmunology
71. Crosstalk between gut microbiota and metastasis in colorectal cancer: implication of neutrophil extracellular traps
    Jiawei Wu, Wenyan Dong, Yayun Pan, Jingjing Wang, Minliang Wu, Yue Yu · 2023 · Frontiers in Immunology
72. Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study
    Yuho Najima, Chikashi Yoshida, Noriyoshi Iriyama, Shin Fujisawa, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai et al. · 2018 · Leukemia Research
73. Cancer immunophenotyping by seven‐colour multispectral imaging without tyramide signal amplification
    Marieke E. Ijsselsteijn, Thomas P. Brouwer, Ziena Abdulrahman, Eileen Reidy, Ana Ramalheiro, Anne Marijne Heeren, Alexander L. Vahrmeijer, Ekaterina S. Jordanova, Noel F.C.C. de Miranda · 2018 · The Journal of Pathology Clinical Research
74. High‐dimensional analyses reveal a distinct role of T‐cell subsets in the immune microenvironment of gastric cancer
    Minyu Wang, Yukuan Huang, Joseph Cherng Huei Kong, Sun Young Yu, Daniela G.M. Tantalo, Han Xian Aw Yeang, Le Ying, Feng Yan, Dakang Xu, Heloise M. Halse et al. · 2020 · Clinical & Translational Immunology
75. Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing
    Eric Alves, Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri, Pilar Blancafort · 2021 · Molecular Therapy — Methods & Clinical Development
76. Bacteria and tumor: Understanding the roles of bacteria in tumor genesis and immunology
    Mingming Zhao, Xiaoxuan Chen, Zhenghao Yang, Xiaodong Yang, Qiang Peng · 2022 · Microbiological Research
77. Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics
    Mitesh Dwivedi, Sanjay Tiwari, Elizabeth Helen Kemp, Rasheedunnisa Begum · 2022 · Heliyon
78. Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells
    Shan, Feng, Cillo, Anthony R., Cardello, Carly, Yuan, Daniel Y., Kunning, Sheryl R., Cui, Jian, Lampenfeld, Caleb, Williams, Asia M., McDonough, Alexandra P., Pennathur, Arjun et al. · 2023 · Science Immunology
79. Targeting persistently activated inflammatory microenvironment to promote chronic wound healing
    Yuxuan Dai, Yu Chen · 2025 · Frontiers in Immunology
80. The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy
    Shanshan Yan, Yaguang Zhang, Bing Sun · 2019 · Science China Life Sciences
81. N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells
    Yi Sun, Jun Jing, Huan Xu, Lingfan Xu, Hailiang Hu, Cai Tang, Shengzhuo Liu, Qiang Wei, Ruiqi Duan, Ju Guo et al. · 2021 · Journal for ImmunoTherapy of Cancer
82. Towards a Quantitative Understanding of Cell Identity
    Zi Ye, Casim A. Sarkar · 2018 · Trends in Cell Biology
83. Cathepsin S inhibition changes regulatory T-cell activity in regulating bladder cancer and immune cell proliferation and apoptosis
    Xiang Yan, Chun Wu, Tao Chen, Marcela M. Santos, Cong-Lin Liu, Chongzhe Yang, Lijun Zhang, Jingyuan Ren, Sha Liao, Hongqiang Guo et al. · 2016 · Molecular Immunology
84. CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells
    Thaís Garcias Moreira, Laila Sampaio Horta, Ana Cristina Gomes-Santos, Rafael Pires de Oliveira, Nina Marí Gual Pimenta de Queiroz, Davide Mangani, Bence Dániel, Angelica Thomas Vieira, Shirong Liu, Ana María Rodrigues et al. · 2018 · Mucosal Immunology
85. Expression of costimulatory and inhibitory receptors in FoxP3+ regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approaches
    Aras Toker, Pamela S. Ohashi · 2019 · Advances in cancer research
86. Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction
    Ji Won Han, Dong Jin Joo, Jong Hoon Kim, Min‐Seok Rha, June‐Young Koh, Hye Jung Park, Jae Geun Lee, Myoung Soo Kim, Soon Il Kim, Eui‐Cheol Shin et al. · 2020 · American Journal of Transplantation
87. G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets
    Ioannis Karagiannidis, Stephanie Jerman, Damian Jacenik, Brandon B. Phinney, Ruoxin Yao, Eric R. Prossnitz, Ellen J. Beswick · 2020 · Frontiers in Immunology
88. YYFZBJS inhibits colorectal tumorigenesis by enhancing Tregs-induced immunosuppression through HIF-1α mediated hypoxia in vivo and in vitro
    Yuli Zhang, Ni Chai, Zhenzhen Wei, Zan Li, Lu Zhang, Mengjie Zhang, J. Ren, Renjie Xu, Xiufeng Pang, Bi-meng Zhang et al. · 2022 · Phytomedicine
89. Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer
    Yuichiro Tsukada, Hideaki Bando, Koji Inamori, Masashi Wakabayashi, Yosuke Togashi, Shohei Koyama, Daisuke Kotani, Satoshi Yuki, Yoshito Komatsu, Shigenori Homma et al. · 2024 · British Journal of Cancer
90. Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response
    Melanie J. McCoy, Chris Hemmings, Chidozie C. Anyaegbu, Stephanie J. Austin, Tracey F. Lee‐Pullen, Timothy J. Miller, Max Kishor Bulsara, Nikolajs Zeps, Anna K. Nowak, Richard Lake et al. · 2017 · Oncotarget
91. Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
    Marie Kroemer, Célia Turco, Laurie Spehner, Julien Viot, Idir Idirène, Adeline Bouard, Elodie Renaude, Marina Deschamps, Yann Godet, Olivier Adotévi et al. · 2020 · Journal for ImmunoTherapy of Cancer
92. Engineered biological nanoparticles as nanotherapeutics for tumor immunomodulation
    Juwita N. Rahmat, Jiayi Liu, Taili Chen, Zhihong Li, Yong Zhang · 2024 · Chemical Society Reviews
93. MicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancers
    Chen Li, Kai Zhang, Jing Chen, Longbang Chen, Rui Wang, Xiaoyuan Chu · 2016 · Oncotarget
94. Deregulated Mucosal Immune Surveillance through Gut-Associated Regulatory T Cells and PD-1+ T Cells in Human Colorectal Cancer
    Hanae Fujimoto, Yoriko Saito, Kenoki Ohuchida, Eiryo Kawakami, Saera Fujiki, Takashi Watanabe, Rintaro Ono, Akiko Kaneko, Shinsuke Takagi, Yuho Najima et al. · 2018 · The Journal of Immunology
95. Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis
    Yiding Li, Zhiming Wang, Huayu Lin, Lisha Wang, Xiangyu Chen, Qiao Liu, Qianfei Zuo, Jianjun Hu, Haoqiang Wang, Junyi Guo et al. · 2020 · Frontiers in Immunology
96. The Multifaceted Role of Long Non-Coding RNA in Gastric Cancer: Current Status and Future Perspectives
    Yifan Li, Lan Lu, Xu Wu, Qianxiu Li, Yueshui Zhao, Fukuan Du, Yu Chen, Jing Shen, Zhangang Xiao, Zhigui Wu et al. · 2021 · International Journal of Biological Sciences
97. Dual Role of TNF and LTα in Carcinogenesis as Implicated by Studies in Mice
    Ekaterina O. Gubernatorova, Almina I. Polinova, Mikhail Petropavlovskiy, Olga A. Namakanova, Alexandra D. Medvedovskaya, Ruslan V. Zvartsev, Georgij B. Telegin, Marina S. Drutskaya, Sergei A. Nedospasov · 2021 · Cancers
98. Easy or Not—The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity
    Jiaqi Huang, Jie Zhang, Zhengyang Guo, Chen Li, Zhen Wei Tan, Junjie Wang, Jianling Yang, Lixiang Xue · 2021 · Frontiers in Immunology
99. Analysis of changes in microbiome compositions related to the prognosis of colorectal cancer patients based on tissue-derived 16S rRNA sequences
    Suk-Jung Choi, Jongsuk Chung, Mi‐La Cho, Donghyun Park, Sun Shim Choi · 2021 · Journal of Translational Medicine
100. Deciphering the influence of urinary microbiota on FoxP3+ regulatory T cell infiltration and prognosis in Chinese patients with non-muscle-invasive bladder cancer
     Yifeng Qiu, Yubo Gao, Chunxiao Chen, Ming Xie, Pengcheng Huang, Qi Sun, Zhipeng Zhou, Biao Li, Jie Zhao, Peng Wu · 2022 · Human Cell